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ABSTRACT  The site of synthesis of  platelet-specific  proteins  remains to  be established. With 
the use of short-term  megakaryocyte-enriched cultures, direct evidence was obtained to show 
that megakaryocytes synthesize the platelet-specific protein, platelet factor 4. A megakaryocyte- 
enriched  fraction  of  rabbit  bone  marrow for culture  was obtained  by centrifugal  elutriation 
and cultured with  [3H]leucine.  Newly synthesized aH-platelet factor 4 was sought by copuri- 
fication  with  added carrier rabbit  platelet  factor 4, using heparin agarose  affinity  chromatog- 
raphy and  immunoprecipitation  with  specific  goat anti-rabbit  platelet  factor 4 antisera.  SDS 
PAGE of the washed immunoprecipitates  demonstrated a [aH]leucine-containing  peak which 
migrated  identically  with  purified  homogeneous  rabbit  platelet  factor  4.  A  second,  slightly 
larger molecular-weight  protein was identified  in the gels also, suggesting that rabbit platelet 
factor 4 may be synthesized as a larger molecular-weight  precursor in  rabbit megakaryocytes. 
These  results  provide  direct  evidence  that  the  platelet-specific  protein,  platelet  factor  4,  is 
synthesized  in  rabbit  megakaryocytes  before  it  is  packaged  into  a-granules  for  release  in 
circulating platelets. 
Several  proteins  found  in  platelet  a-granules  are  unique  to 
platelets and presumably unique to megakaryocytes, the bone 
marrow precursor cell of platelets.  The best known  of these 
proteins  are  platelet  factor  4,  fl-thromboglobulin,  and  the 
platelet-derived  growth  factor  (1-9).  During  normal  blood 
coagulation,  the platelet undergoes the "release reaction",  se- 
creting  a-granule  constituents  to  the  extracellular  melieu. 
While  the  precise  role  of the  released  proteins  is  unknown, 
these  platelet  release  proteins  have been  shown  to  have  the 
capacity to profoundly influence inflammation, wound healing, 
DNA synthesis, and cell growth. They may be important also 
in the development of atherosclerosis in humans (10-17). 
Platelet factor 4  and fl-thromboglobulin are the most fully 
characterized  of the  secreted  proteins.  The  complete  amino 
acid sequence of each protein has been published (18-21). No 
information is available on the synthesis of these proteins and 
little  is  known  on  how  they  are  packaged  into  a-granules. 
Platelets  synthesize  little  if any  protein;  it  is  assumed  that 
megakaryocytes synthesize platetet-specific proteins. Alterna- 
tively, these proteins may be synthesized elsewhere and actively 
taken up by platelets for storage and subsequent release. Sup- 
port for megakaryocytic origin of platelet factor 4 was recently 
provided by the demonstration in human bone marrow prep- 
arations that only megakaryocytes (7) and potential megakary- 
ocyte  progenitors  (8)  showed  positive  immunofluorescence 
after incubation with purified fluorescein-labeled rabbit anti- 
human  platelet  factor  4;  these  results  do  not  preclude  the 
uptake of platelet factor 4 by megakaryocytes after its synthesis 
elsewhere. 
The present experiments use short-term rabbit marrow cul- 
tures  enriched  for megakaryocytes by centrifugal  elutriation 
(22,  23)  to  provide  direct  evidence  that  platelet  factor 4  is 
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MATERIALS  AND  METHODS 
Harvesting of Megakaryocytes:  Megakaryocytes were harvested 
from bone marrow from New Zealand white rabbits by methods adapted from 
those described previously (21, 22). Briefly, 8-I0 rabbits were anesthesized with 
Nembutal (Abbott  Laboratories,  North  Chicago,  IL)  and  were  sacrificed by 
cardiac  puncture.  The  femora,  tibiae, and  humeri  were  removed  aseptically, 
cleaned of adherent tissue, and kept in cold Hanks' balanced salt solution (HBSS; 
Gibco Laboratories, Grand Island Biological  Co., Grand Island, NY), containing 
50 U/ml penicillin and 50 U/ml streptomycin. After the bones were opened with 
a  rongeur,  the marrow was scooped free with a  spatula and the bone marrow 
tissues were immersed in 10 ml of cold phosphate-buffered saline (PBS) (pH 6.7), 
supplemented with  1.5% bovine serum albumin (BSA),  containing 50  U/ml 
penicillin and  50  U/ml  streptomycin,  in  a  9-cm  plastic petri  dish  (Costar 
Packaging, Cambridge, MA). The tissues were cut with small scissors into 2-ram 
pieces and transferred to a  50-ml plastic tube (Falcon Labware, Oxnard, CA). 
Marrow suspensions were vigorously  pipetted 18-20 times with wide-bore pasteur 
pipettes to break the cell clumps. 
The marrow cells were filtered through a stainless steel sieve (100 mesh) and 
poured into 50-ml plastic tubes. The bone marrow suspensions were centrifuged 
at 150 g for 5 min at 4°C, and the cells washed two times with PBS supplemented 
with 1.5% BSA (pH 6.7). The marrow ceils were suspended and introduced into 
the Beckman elutriator (Beckman Instruments, Inc., Spinco Div., Palo Alto, CA) 
at 1 x  l0  g celis/ml. The elutriator buffer was PBS supplemented with 1.5% BSA 
(pH 6.7) and precooled to 4°C. The cell elutriator was washed with 70% ethanol 
to provide asepsis before starting the separation and maintained at 4°C. Mega- 
karyocytes were harvested with a  buffer flow of 30 ml/min and a  centrifuge 
speed of either 2,793  rpm (chamber fractions >10 mm/h)  or  1,975 rpm (>20 
ram/h).  The  megakaryocytes from  the elutriator chamber were recovered by 
resuspending the pellet with a 5-ml syringe fitted with an 18-gauge needle. Cells 
from other fractions of the elutriator run were also collected and used in control 
cultures. The harvested megakaryocytes were washed two times with calcinm- 
and  magnesinm-free Hanks" Buffered  Salts Solution (HBSS)  containing 1.5% 
BSA (pH 7.2) by centrifugation at 200 g for 5 min at 4°C. The total nucleated 
cell count  was  electronically determined with  a  Coulter Counter  Model  B. 
Megakaryocytes in cell suspensions were stained with hematoxylin and counted 
microscopically  as described previously  (7).  1.2-3.0 ×  107/ml cells  were recovered 
in 4 ml of calcium- and magnesium-free HBSS; megakaryocytes  comprised 1-4% 
of the isolated total cell population. Control cultures contained 0.1% or fewer 
megakaryocytes. Fig.  1 shows a  low power micrograph of the harvested mega- 
karyocytes stained with hematoxylin. 
Culture  of  Megakaryocytes:  The  isolated megakaryocytes were 
cultured in HBSS containing 2.3% BSA, pH 7.4, in siliconized glass tubes (19 × 
140 mm) covered with caps. Cultured cells were incubated under 5% COx at 37°C 
for 3 h with 2-5 ×  10  '~' cells in 2.0-2.5 ml ofmedinm. Solutions and culture media 
were sterilized by passage through 0.22-/tin  filters (Millipore Corp.,  Bedford, 
MA).  The  cell culture systems were  incubated for  up  to  48  h  at  37°C.  The 
morphological appearance of the cell systems was largely unchanged. Trypan 
blue exclusion was used to assess the bone marrow cell viability. As judged by 
morphological appearance,  up  to  50%  of the  megakaryocytic cells excluded 
Trypan blue. The  percentage of cells excluding Trypan blue did not decrease 
over 48 h of culture, which supported previous results on liquid cultures of guinea 
pig megakaryocytes (24).  The morphological appearance of the cells remained 
constant, suggesting that megakaryocytes maintained their viability in culture. 
Morphological  Observations  of Megakaryocytes:  Mega- 
karyocytes were washed one time with Tyrode's solution and fixed for 1 li at 4°C 
with 2.5% glutaraldehyde in Tyrode's solution, postfixed in 1% osmium tetroxide, 
dehydrated in continuous ethanol, and embedded  in Epon 812.  Sections were 
prepared and examined with a Pliilips E.M.201  electron microscope. 
Preparation  of Purified  Rabbit Platelet Factor 4 and Anti- 
sera Against Rabbit Platelet Factor 4:  Rabbit platelet factor 4 was 
purified by affinity chromatography on columns of direct linked heparin Seph- 
arose (18, 25, 26), as described in detail previously. The protein is homogeneous 
as judged by SDS polyacrylamide  electrophoresis and by N-terminal amino acid 
sequence analysis (27).  Anti-rabbit platelet factor 4  serum was obtained from 
goats after immunization with purified rabbit platelet factor 4. The antisera is 
monospecific for  platelet factor 4,  on  the  basis of a  single precipitin line of 
identity with purified  rabbit  platelet factor 4  and  a  rabbit  platelet lysate in 
immunodiffnsion analysis and on a single precipitin arch observed in immunoe- 
lectrophoresis analysis (27). 
Iodination  of Rabbit  Platelet  Factor 4:  Platelet factor 4  was 
iodinated by the chloramine T  technique (28)  as described in detail previously 
(18). 
FIGURE  1  Photomicrograph  taken  from  megakaryocyte-enriched 
cultures and stained with  hematoxylin, x  50. 
Immunofluorescence  Studies:  Smears prepared from megakary- 
ocyte-enriched suspensions were dried and fxed in neutralized formalin in PBS 
(pH 7.2) for 30 min. Fluorescent staining of smears with monospecific goat anti- 
rabbit platelet factor 4 was performed by the method of Ortega and Mellors (29), 
using an indirect technique as described in detail previously (6). Preparations of 
nonimmune  serum  and  specific antiplatelet factor  4  antisera adsorbed  with 
purified  rabbit  platelet factor 4  were  used  to  establish the  specificity of the 
immunofluorescence observed. 
Synthesis of Ptatelet Factor 4 in the Culture of Megakary- 
ocytes:  The cultured megakaryocytes were incubated at 37°C with HBSS 
containing 2.3%  BSA,  pH  7.4,  and  5 ~Ci/ml or  l0 #Ci/mI [:~H]leucine (New 
England Nuclear, Boston, MA). After an appropriate labeling  period, the reaction 
was stopped by addition of one-tenth volume of l0 mM leucine in HBSS and by 
cooling to 0°C. The radiolabeled megakaryocytes were washed three times by 
centrifuging at 200 g for 5 min at 4°C with cold PBS containing 1.5% BSA (pH 
6.7). The megakaryocytes were resuspended in 0.15  M NaCI,  l0 mM phosphate 
(pH 7.5), containing 0.5% Triton X-100 and  100 U/ml Trasylol (FBA Pharma- 
ceuticals, New York) and disrupted for 10 s with sonication. The final volume of 
labeled megakaryocyte-enricbed  cell suspensions was adjusted at 2-6 x  l06 cells/ 
ml. After 15-min extraction at 0°C, the extract was centrifuged at 10,000 g for 30 
rain at 4°C, and the small pellet of Triton X-100-insoluble material was discarded. 
Purification  of Newly Synthesized Heparin  Neutralizing 
Protein  with  Heparin  Sepharose Column:  The  Triton X-IO0 
treated soluble supernatant was diluted 1: l 0 with 0.15 M NaCl, l0 mM phosphate 
(pH 7.4). The diluted cell extract was applied to a  l  x  5 cm column containing 
1.5 ml of heparin-Sepharose equilibrated with 0.15  M  NaC1,  10 mM Tris, HCI 
pH 8.6. The column was washed with 200 ml of 0.5  M  NaCl,  l0 mM Tris HCI 
(pH 8.7), and eluted in a  linear gradient between 10 ml of 0.5  M  NaCl,  l0 raM 
Tris HC1 (pH  8.7),  and  l0 ml of 3  M  NaCL  l0 mM Tris HCI (pH  8.7).  The 
eluates were collected in l-ml aliquots in plastic tubes containing 2 lag/ml  heparin. 
Conductivity was measured with a conductivity meter. The radioactivity in the 
eluates was counted with Dimilume-30 (Packard Instrument Co., Inc. Downers 
Grove,  IL) in a  Searle Mark III liquid scintillation spectrometer (Amersham 
Corp., Arlington Heights, IL). 
Immunoprecipitation  of Newly Synthesized Protein with 
Anti-Rabbit  Platelet Factor 4:  A double antibody immunoprecipita- 
tion procedure was used with Triton X-100-treated supernatanl or eluates from 
the beparin Sepharose column. Immunoprecipitations were done immediately 
after preparing the samples. Heparin column einates were mixed with 0.02 ml of 
antiserum (or normal goat serum), 50 #1 of 0.15 M NaCI, 50 mM phosphate (pH 
7.5), containing 2.5% Triton X-100 and 2.5% deoxycholate, 100 ,M of 150 #1 of 
0.25 M NaCI, 50 mM phosphate (pH 7.5), containing 5 mg/ml BSA and 2 #g/ml 
heparin, in a volume of 250/d. The reaction mixtures were incubated for 24 h at 
4°C in Eppendorf microtest tubes previously soaked in 1% BSA. 8 #1 of rabbit 
516  THe  }OURNAL OF  CELL BIOLOGY • VOLUME 96,  1983 anti-goat 3,-globulin (Cappel Laboratories Inc., CochramviUe, PA) was then added 
to reaction mixtures and the reaction mixture was incubated for 20 h at 4°C. 
Immunoprecipitates were recovered by centrifugation at 8,000 g for 5 rain in 
a Beckman microfuge (Beckman Instruments, Inc.) and were washed three times 
with ice-cold 0.15 M  NaC1, 0.5% Triton X-100, 10 mM phosphate (pH 7.4), and 
once with 0.15 M  NaCI,  10 mM  phosphate (pH 7.4). The washed precipitates 
were dissolved with 0.2 ml of NCS (New England Nuclear, Boston, MA), and 
the radioactivity was counted with neutralizer (Research Products International 
Corp., Mt. Prospect, IL) in a  liquid scintillation spectrometer. A correction for 
nonspecific precipitation was made by substracting the radioactivity in precipi- 
tates derived from the normal serum control. The  radioactivity in nonspecific 
precipitates  did  not  exceed  10%  of the  total  precipitate  radioactivity in  any 
analysis. 
Analysis of Labeled Immunoprecipitates on SDS Gel:  The 
washed  immunoprecipitate  was  subjected  to  electrophoresis  in  a  10%  SDS 
polyacrylamide  gel according to the modification of Weber and Osborn (30). The 
washed pellet was resuspended in 20/~1 of 0.15 M  NaC1, 10 mM phosphate and 
dissolved in 20#1 of 20 mM Tris, 2 mM EDTA, 2% SDS,  15% sucrose, 80 #g/ml 
Pyramin and 80 mM dithiothreitol. It was then boiled for 3 min and applied to 
the  tops of gels (0.5  x  7  cm).  The gels contained  10% acrylamide and  were 
equilibrated with a  gel buffer composed of 1% SDS and  100 mM Tris, pH 7.4. 
Protein bands were stained with Coomassie Blue, and 2-mm slices of gels were 
cut for analysis. Slices were transferred to scintillation vials and solubilized as 
described by Ames (3 l). Radioactivity of the sliced gels were measured in a liquid 
scintillation spectrometer. 
RESULTS 
Morphological  Observations on Harvested 
Megakaryocytes 
Preliminary  experiments  were  done  to  seek a-granule-like 
particles  in  cultured  megakaryocytes.  Electron  micrographs 
show that the megakaryocytes harvested after 48 h  of culture 
had abundant cytoplasmic granules (Fig. 2 A ). Higher magni- 
fications showed greater detail of these granules (Fig. 2 B). The 
granules observed appear in electron micrographs to be iden- 
tical to granules found  in platelets; isolation and  biochemical 
characterization  of the  megakaryocytic granules  are required 
to definitively establish the precise relationship of megakary- 
ocyte and platelet granules. 
Immunofluorescence Studies 
Experiments were done to detect platelet factor 4 antigen in 
the  megakaryocyte  preparations.  When  the  megakaryocyte- 
enriched suspensions and cultured megakaryocytes were incu- 
bated  with  goat  anti-rabbit  platelet  factor  4  antiserum  and 
fluorescein-conjugated  rabbit anti-goat y-globulin, prominent 
immunofluorescent  staining  was  observed  in  all  megakaryo- 
cytes, similar to that reported previously using identical stain- 
ing techniques on human bone marrow smears (7).  No mega- 
karyocytes were stained  when normal goat serum was substi- 
tuted for goat anti-platelet factor 4 serum. The positive staining 
of megakaryocytes was sharply reduced by prior adsorption of 
goat anti-platelet factor 4 serum with purified platelet factor 4. 
The  platelet  factor  4  antigen  in  megakaryocytes  appears 
roughly equal in fluorescent staining to that in platelets. 
Incorporation of [ 3H]leucine into Platelet Factor 
4 Antigen 
Platelet  factor 4  antigen  in  disrupted  megakaryocytes was 
precipitated  by double  antibody  immunoprecipitation  as  de- 
FIGURIE  2  An electron micrograph of megakaryocytes from a preparation of megakaryocyte-enriched  cultures.  The figure on the 
left (A) demonstrates an intact megakaryocyte (x 5,000) and on the right (B) is a picture at higher power (x 50,000) of the section 
outlined  in  the  intact  megakaryocyte. The darkly stained granules  (A)  are  identical  in  appearance to  platelet ~-granules,  the 
subcellular locus of PF4 in intact platelets. 
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into platelet factor 4 antigen varied linearly with time (Fig. 3). 
A  correction  for nonspecific precipitation  was  made by sub- 
tracting the radioactivity incorporated after precipitation with 
normal  goat  serum.  This  correction  was  never  >10%  of the 
total radioactivity precipitated. 
Elution  Pattern of Newly Synthesized  Product 
on a Heparin  Affinity Column 
Megakaryocytes (6 X  105/ml) were cultured as noted above 
with [aH]leucine (10/aCi/ml) for 2 h. The megakaryocytes were 
then washed three times with cold PBS containing  1.5% BSA 
at  4°C,  and  disrupted  by  sonication.  This  extract  (6  x  105 
megakaryocytes/ml, 2 ml) was applied to 1.5-ml heparin affin- 
ity column  as described  in  Materials  and  Methods.  A  linear 
salt gradient was used to elute labeled protein. Fig. 4 shows a 
single peak of radioactivity which  appeared  at a  molarity of 
1.0-1.5  M  NaCI. Recovery of [3H]leucine in this fraction was 
0.6%.  Cycloheximide  (100  #g/ml)  inhibited  incorporation  of 
radioactivity  into  this  peak  by  77%.  Boiled  megakaryocytes 
and megakaryocyte poor elutriator fractions had <10% of the 
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FIGURE  4  The elution  pattern  of  newly synthesized  protein  from 
the megakaryocyte-enriched culture system from a heparin-agarose 
column.  The column  was washed  extensively with  500 m/vl  NaCI 
and eluted with  a  linear 0.5-1.5  M  NaCI gradient. A  large peak of 
radiolabeled  material  elutes  in  the  range of  1.3  M  NaCI  and  co- 
elutes with  carrier  rabbit  platelet factor 4.  The  elution  pattern  of 
newly synthesized protein was the same as that of the 12Sl-labeled 
purified rabbit platelet factor 4. 
SDS Gel Electrophoretic  Profile of an 
Immunoprecipitate of Newly Synthesized 
Antigen by Cultured Megakaryocyte 
Platelet factor 4  containing  fractions from heparin  agarose 
chromatography  were  immunoprecipitated  as  noted  above. 
[3Hlleucine  recovered  in  the  washed  immunoprecipitate  of 
material recovered from the heparin agarose column averaged 
~10-15%.  The radioactive immunoprecipitable platelet factor 
4  antigen  (120-rain  incubation)  was dissolved  in  buffer  (see 
Materials  and  Methods)  and  boiled for 3  min at  100°C  and 
analyzed  by  SDS  polyacrylamide  gels  as  described  also  in 
Materials and Methods. This analysis consistently showed two 
peaks  of radioactivity  (Fig.  5).  The  most  rapidly  migrating 
peak  (~44%  of  aH  applied,  ~10,000  mol  wt)  co-migrated 
precisely with purified rabbit platelet factor 4 shown in the gel 
before  slices  were  prepared  for  measurement  of [all]labeled 
protein  (Fig.  5).  This material co-eluted  with carrier platelet 
factor 4 from heparin agarose and coprecipitated with carrier 
platelet factor 4 with specific antiplatelet factor 4 antisera. 
A  slightly less rapidly migrating protein peak (~46% of aH 
applied,  ~14,000  tool  wt)  was  found  consistently  in  gels  of 
immunoprecipitates from megakaryocyte cultures. The identity 
of this peak has not been definitively established. A very small 
peak of radioactivity (~28-30 rain, Fig. 5) were variably found 
in different preparations.  These minor peaks (-10%  of total) 
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FIGURE  3  Demonstration 
of  the  incorporation  of 
[aH]leucine  into  platelet 
factor 4 antigen. Linear in- 
corporation is found for 90 
min  and,  in  other  experi- 
ments, for up to 120 rain. 
FIGURE  5  SDS gel electrophoresis of the material eluting from the 
heparin agarose column which  has been subsequently precipitated 
by  a  double  antibody  technique,  using  goat  anti-rabbit  platelet 
factor  4  and  rabbit  anti-goat  IgG.  DPM  in  slices  of  the  gel  is 
compared with a photograph of the gel containing carrier purified 
rabbit platelet factor 4  stained with  Coomassie Blue before slicing 
of the gel for measurement of all-labeled protein. A  peak of radio- 
activity  is  found  in  the  SDS  gel  which  co-migrates  with  purified 
platelet factor  4.  The  migration  of  marker  proteins  is  shown  for 
reference.  Bovine  serum  albumin  (68,000),  carbonic  anhydrase 
(30,000),  lysozyme (14,300),  and PF4. 
the small amounts of each  found and/or  the  failure of these 
small radioactive peaks to be found in repeat experiments. 
DISCUSSION 
While it is generally assumed that platelet-specific proteins are 
synthesized in megakaryocytes for packaging and subsequent 
release in circulating platelets, the direct demonstration of the 
synthesis  of platelet-specific  proteins  has  not  been  reported. 
These studies were designed to determine whether megakary- 
ocytes synthesize the platelet-specitic protein, platelet factor 4. 
The purification of a newly synthesized protein which copuri- 
fled with homogeneous rabbit platelet factor 4  using heparin 
affinity  chromatography  and  which  coprecipitated  with  ho- 
mogeneous  rabbit  platelet  factor  4  using  specific  goat  anti- 
rabbit  platelet  factor  4  provides  strong  direct  evidence  that 
megakaryocytes have  synthesized  platelet  factor  4  and  that 
megakaryocytes are the site of synthesis of the platelet-specific 
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cultures  did not synthesize  this protein,  providing additional 
evidence that megakaryocytes alone synthesize platelet  factor 
4.  This  view  is  strengthened  by  our  previous  finding  that 
fluorescein-labeled specific antiplatelet factor 4 antisera reacted 
with megakaryocytes but not with other cells  in  rabbit bone 
marrow (7). 
Criteria used to establish that the newly synthesized, purified 
protein  is  platelet  factor  4  are:  the  protein  co-elutes  from 
heparin agarose at the same ionic strength as purified platelet 
factor  4;  the  protein  is  precipitated  by  a  specific  goat  anti- 
rabbit  platelet  factor  4  antisera;  and  the  newly  synthesized 
protein migrates in polyacrylamide gels identically with rabbit 
platelet factor 4 purified to apparent homogeneity. Cyclohex- 
imide, an inhibitor of protein synthesis, blocks the synthesis of 
this platelet factor 4-like protein when added to the megakary- 
ocyte-enriched culture systems. 
A  slower  migrating  (SDS  gel  electrophoresis)  [3H]leucine- 
labeled  protein copurifies with platelet  factor 4.  This protein 
binds to heparin agarose, is eluted from heparin agarose with 
carrier platelet factor 4, and is precipitated together with plate- 
let factor 4 by specific anti-rabbit platelet factor 4 antisera, and 
seems likely to be the precursor of platelet factor 4 as synthe- 
sized in the megakaryocyte. Such a precursor would be impor- 
tant to identify and would provide important information on 
the mechanism of synthesis of platelet a-granule proteins. We 
have not established  that the larger-molecular-weight  peak is 
the precursor of the smaller-molecular-weight peak. Data from 
preliminary  pulse-chase  experiments  over an  extended  incu- 
bation period did not support a precursor/product relationship 
between these two peaks of radioactivity. It is possible that the 
antiserum to rabbit platelet factor 4 reacts with a second, newly 
synthesized protein in cell extracts,  such as the PSPz protein, or 
the  Mr  ~  12,000 heparin-binding  protein purified  from rabbit 
platelets by Muggli et al.  (32).  Further studies are required to 
elucidate  the identity of this higher-molecular-weight  protein 
precipitated  by our anti-PF4  antiserum.  Testing  of the  anti- 
rabbit platelet  factor 4  antisera  by immunodiffusion  did  not 
demonstrate cross-reacting protein species. 
As a result  of the abnormally low frequency of megakaryo- 
cytes in marrow (<0.1% of nucleated cells), biochemical studies 
of megakaryocytes have been possible only following isolation 
and purification on the basis of cell size (22, 23, 33-36), density 
(37),  or both (1, 9,  38-41).  Megakaryocytes isolated  by these 
procedures have been shown to contain factor VIII antigen (1), 
fibrinogen  (39),  5-hydroxytryptamine  (40),  and a  platelet-de- 
rived growth factor-like material (9, 39). Cultures of megakary- 
ocytes have been established (24, 42) and used to demonstrate 
the  synthesis  of thromboxane  B2  from  rat  marrow  (22)  and 
actin (43), and Factor VIII (1) antigen from guinea pig marrow. 
Platelets  and megakaryocytes also share microtubules,  micro- 
filaments,  and  a  system  of invaginated  membranes  (44-48), 
compatible  also  with  the  precursor  cell,  the  megakaryocyte, 
synthesizing organdies found in the product cell, the platelet. 
The  results  presented  here  provide  direct  evidence  that  the 
platelet-specific  a-granule protein, platelet factor 4, is synthe- 
sized in megakaryocytes for ultimate packaging and subsequent 
release by platelets. 
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